← back to search

Peter K. Plinkert

Heidelberg University · DE
Area of research
Otorhinolaryngology · Sensory Systems
Research interest
Research interests include Head and Neck Cancer Studies, Hearing, Cochlea, Tinnitus, Genetics, Hearing Loss and Rehabilitation, and Salivary Gland Tumors Diagnosis and Treatment.
h-index
39
citations
6,729
works
257
NIH funding
primary concept
email

Recent publications

Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy
Radiation Oncology 2025cited by 1position: middledoi
Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy
Technology in Cancer Research & Treatment 2024cited by 5position: middledoi
Radiotherapy Effects on Airway Management in Patients with Nasopharyngeal Cancer
Cancers 2024cited by 3position: middledoi
Establishment of a Machine Learning Model for the Risk Assessment of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
International Journal of Molecular Sciences 2023cited by 18position: middledoi
Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
Cancers 2022cited by 9position: middledoi
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability
Radiation Oncology 2022cited by 6position: middledoi
Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2021cited by 26position: middledoi
Individualized 3D-Printed Tissue Retraction Devices for Head and Neck Radiotherapy
Frontiers in Oncology 2021cited by 15position: middledoi
Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience
Radiology and Oncology 2021cited by 11position: middledoi
Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma
Molecular Cancer Research 2021cited by 7position: middledoi
Retrospective analysis of outcome and toxicity after postoperative radiotherapy in patients with squamous cell carcinoma of the lip
Tumori Journal 2021cited by 6position: middledoi
Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC
British Journal of Cancer 2020cited by 50position: middledoi
Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma
Cancers 2020cited by 43position: middledoi
<p>Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy</p>
Cancer Management and Research 2020cited by 20position: middledoi
Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial
Radiation Oncology 2020cited by 15position: middledoi
Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands
Frontiers in Oncology 2020cited by 13position: middledoi
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Journal of Nuclear Medicine 2019cited by 1,414position: middledoi
Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience
International Journal of Radiation Oncology*Biology*Physics 2019cited by 59position: middledoi
Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience
Cancers 2019cited by 33position: middledoi
Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control
Cancers 2019cited by 26position: middledoi
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
International Journal of Radiation Oncology*Biology*Physics 2019cited by 22position: middledoi
Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma
Cancers 2019cited by 15position: middledoi
The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience
Oral Oncology 2019cited by 15position: middledoi
Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
Frontiers in Oncology 2019cited by 11position: middledoi
Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer
Cancers 2019cited by 8position: middledoi
Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
Radiation Oncology 2019cited by 7position: middledoi
Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck
Frontiers in Oncology 2019cited by 4position: middledoi
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
European Journal of Nuclear Medicine and Molecular Imaging 2018cited by 94position: middledoi
Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution’s Clinical Experience
Cancers 2018cited by 16position: middledoi
Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage
PLoS ONE 2018cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health23 papers (2015–2025)Jochen Heß · German Cancer Research Center22 papers (2012–2023)Sebastian Adeberg · Goethe University Frankfurt20 papers (2018–2024)Thomas Held · Heidelberg University18 papers (2018–2025)Kristin Lang · Heidelberg University17 papers (2019–2024)Klaus Herfarth · Universitätsklinik für Strahlentherapie14 papers (2018–2022)Karim Zaoui · Heidelberg University13 papers (2012–2021)Christian Freudlsperger · University Hospital Heidelberg12 papers (2014–2024)Sati Akbaba · German Cancer Research Center12 papers (2019–2021)Stefan Rieken · University Medical Center11 papers (2018–2021)Niels Grabe · Heidelberg University10 papers (2012–2020)Christa Flechtenmacher · Heidelberg University9 papers (2012–2021)Denise Bernhardt · TUM Klinikum9 papers (2018–2022)Gerhard Dyckhoff · Heidelberg University8 papers (2013–2025)Kolja Freier · University Hospital Heidelberg7 papers (2014–2020)Jürgen Hoffmann · University of Tübingen7 papers (2014–2025)Annette Affolter · Johannes Gutenberg University Mainz7 papers (2015–2020)Dana Holzinger · German Cancer Research Center6 papers (2012–2021)Rami A. El Shafie · University Medical Center5 papers (2019–2022)Wilko Weichert · German Cancer Research Center5 papers (2014–2020)